Palladian Partners has been instructed by the Executive Officer of NIGMS, in consultation with the Institute Director, that due to the extenuating circumstances with the government shutdown, the PGRN meeting will no longer be held on October 16 and 17. Anyone who has paid the $100 convenience fee or the $60 for the social event will be refunded in full. We will also take care of canceling everyone’s hotel room at the Blackwell Hotel and Conference Center. If for some reason you do not wish to have your hotel room canceled, please immediately contact the hotel directly and ask to be removed from the PGRN block.
Conference Hosts Wolfgang Sadee, XGEN PGRN Groups Pharmacogenetics in Rural and Underserved Populations (NWAP) Pharmacogenomics of Anticancer Agents Research Group (PAAR) Pharmacogenomics of Anticancer Agents Research in Children (PAAR4Kids) Pharmacogenomics of Anti-Platelet Intervention-2 Study (PAPI–2) Pharmacogenomics and Risk of Cardiovascular Disease (PARC) Pharmacogenomics of Arrhythmia Therapy (PAT) Pharmacogenomics Evaluation of Antihypertensive Responses (PEAR) Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD) Pharmacogenetics of Asthma Treatment (PHAT) Pharmacogenomics of Rheumatoid Arthritis Therapy (PhRAT) Pharmacogenetics of Membrane Transporters (PMT) Pharmacogenetics of Nicotine Addiction and Treatment (PNAT) Pharmacogenetics of Phase II Drug Metabolizing Enzymes (PPII) Expression Genetics in Drug Therapy (XGEN) PGRN Network Resources Baylor College of Medicine Human Genome Sequencing Center (BCM–HGSC) PharmacoGenomic Discovery and Replication in Very Large Patient Populations (PGPop) PGRN and Center for Genomic Medicine Global Alliance (PGRN–CGM) PGRN Ontology Network Resource (PHONT) PGRN Statistical Analysis Resource (P–STAR) University of Washington Next Gen Sequencing (UW–NEXTGEN) Washington University Next Gen Sequencing (WU–NGS) PGRN Partners Catalyzing Research in Pharmacogenomics (PharmGKB) Program Planning Committee Allan Rettie Caryn Lerman Deanna Kroetz Julie Johnson Marylyn Ritchie Ronald Krauss PGRN Mission Statement http://www.pgrn.org/display/pgrnwebsite/Mission Statement Vision To lead discovery and advance translation in genomics in order to enable safer and more effective drug therapies.